Philips reports Q2 comparable sales growth and higher margin

What happened?

1. Royal Philips said its quarterly comparable sales were up 4%, as all segments expanded.
2. The company said its Adjusted EBITA margin rose to 16.4%, with an effective 4.2% benefit from a US tariff refund included.
3. According to the company, comparable order intake fell 1%; gains in Diagnosis & Treatment were cancelled out because some large Connected Care orders moved to the third quarter.
4. The company said Diagnosis & Treatment's comparable sales rose 2%, while its Adjusted EBITA margin reached 13.9%, including an approximately 4.6% benefit from a US tariff refund.
5. According to the company, Connected Care's comparable sales grew 2%, and its Adjusted EBITA margin climbed to 17.8%, with an approximately 6.1% boost from a US tariff refund included.

According to Royal Philips, its second-quarter comparable sales rose 4%, every segment grew, and Adjusted EBITA margin reached 16.4%; this included an effective 4.2% gain from a US tariff refund. Philips reiterated its full-year comparable sales growth outlook and increased its Adjusted EBITA and free cash flow outlook to reflect the US tariff refund, the company said.

A machine summary written from the reports listed below; read them for the full account. How summaries are made and what is checked.